Abstract
Introduction
Impulsive compulsive behaviors (ICBs) in Parkinson’s disease (PD) are debilitating disorders of repetitive, excessive, and compulsive nature affecting up to one third of PD patients. Objectives are to address clinical, psychiatric, and cognitive characteristics of ICBs and to define risk factors in PD patients in the initial motor stage, followed up for 5 years.
Methods
We analyzed 106 consecutive PD outpatients at Hoehn and Yahr disease stage 1 and 125 healthy controls. The participants were assessed for the presence of any ICB using the current clinical criteria and underwent comprehensive clinical, psychiatric, and neuropsychological evaluations. The patients completed the same protocol at Years 1, 2, 3, and 5.
Results
ICBs were present in 21 (19.8%) PD patients and 13 (10.4%) healthy controls at baseline. Prevalence of ICBs increased to 29.2% at Year 5, significantly after Year 2. Multiple ICBs were present in 4,7% and 61.9% of PD-ICBs at the baseline and Year 5, respectively. ICBs resolved in 30% of cases (most often compulsive eating). Dopamine agonist treatment at the baseline carried five times higher risk of having or developing ICB(s) anytime during follow-up. We identified risk factors for compulsive eating (dopamine agonist treatment at baseline), hypersexuality (males), compulsive buying (depression and younger age), and punding (younger age and higher levodopa dose at baseline). Significant interaction of rate of motor progression and ICB diagnosis was shown.
Conclusions
PD patients showed increasing frequency of most ICBs during the 5-year follow-up. Specific risk factors were identified for different types of ICBs.
Similar content being viewed by others
References
Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson's disease. Mov Disord 30:121–127
Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson's disease. Curr Opin Neurol 17:393–398
Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595
Fan W, Ding H, Ma J, Chan P (2009) Impulse control disorders in Parkinsons disease in a Chinese population. Neurosci Lett 465:6–9
Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P (2017) ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry 88:317–324
Sharma A, Goyal V, Behari M, Srivastva A, Shukla G, Vibha D (2015) Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using "Questionnaire for impulsive-compulsive disorders in Parkinson's disease" (QUIP). Ann Indian Acad Neurol 18:49–59
Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M (2011) Impulse control disorders in Parkinson disease: a multicenter case- control study. Ann Neurol 69:986–996
Kon T, Ueno T, Haga R, Tomiyama M (2018) The factors associated with impulse control behaviors in Parkinson's disease: a 2-year longitudinal retrospective cohort study. Brain Behav 8:e01036
Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A, DIGPD Study Group (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91:e189–e201
Prange S, Danaila T, Laurencin C, Caire C, Metereau E, Merle H, Broussolle E, Maucort-Boulch D, Thobois S (2019) Age and time course of long-term motor and nonmotor complications in Parkinson disease. Neurology 92:e148–e160
Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol 55:181–184
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, American Psychiatric Association, Washington
Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254–1257
McElroy SL, Keck PE Jr, Pope HG Jr, Smith JM, Strakowski SM (1994) Compulsive buying: a report of 20 cases. J Clin Psychiatry 55:242–248
Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405
Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428
Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 24:1461–1467
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649–2653
Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriat Psychiatry 21:1078–1085
Cooper J, Sagar HJ, Jordan N, Harvey NS, Sullivan EV (1991) Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 114:2095–2212
Hooper HE (1958) The Hooper visual organization test. Western Psychological Service, Los Angeles
Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsych Clin Neurosci 4:134–139
Weintraub D, Papay K, Siderowf A (2013) Parkinson's progression markers initiative. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study. Neurology 80:176–180
Smith KM, Xie SX, Weintraub D (2016) Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry 87:864–870
Fasano A, Petrovic I (2010) Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 15:560–573
Martini A, Weis L, Fiorenzato E, Schifano R, Cianci V, Antonini A, Biundo R (2019) Impact of cognitive profile on impulse control disorders presence and severity in Parkinson's disease. Front Neurol 10:266
Martini A, Dal Lago D, Edelstyn NMJ, Grange JA, Tamburin S (2018) Impulse control disorder in Parkinson's disease: a meta-analysis of cognitive, affective, and motivational Correlates. Front Neurol 9:654
Funding
All authors have been supported by the Ministry of Education, Science, and Technological Development, Republic of Serbia (Project No. 175090). T. Stojkovic and E. Stefanova receive Alzheimer Association grant for Promoting Diversity, from 2018 and honoraria from Actavis. I. Petrovic received honoraria from Salveo and Actavis. M. Svetel and N. Dragasevic-Miskovic received honoraria from Savleo and Hofman Roche. V. Kostic received honoraria from Salveo and Novartis. V. Markovic, I. Stankovic and S. Radovanovic report no additional financial support.
Author information
Authors and Affiliations
Contributions
All listed authors contributed to creation of this manuscript and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. VM-1) study concept/design; analysis/interpretation of data; 2) drafting the manuscript for content; 3) final approval of the version to be submitted. IS-1) study concept/design; analysis/interpretation of data; 2) drafting the manuscript for content; 3) revision of the version to be submitted. IP-1) study concept; interpretation of data; 2) drafting the manuscript for content; 3) revision of the version to be submitted. TS-1) acquisition of data; analysis/interpretation of data; 2) revising the manuscript for content; 3) revision of the version to be submitted. NDM-1) study concept; interpretation of data; 2) drafting the manuscript for content; 3) revision of the version to be submitted. SR-1) study concept/design; analysis/interpretation of data; 2) drafting the manuscript for content; 3) revision of the version to be submitted. MS-1) acquisition of data; analysis/interpretation of data; 2) revising the manuscript for content; 3) revision of the version to be submitted. ES-1) acquisition of data; analysis/interpretation of data; 2) revising the manuscript for content; 3) revision of the version to be submitted. VK-1) study concept/design; analysis/interpretation of data; 2) drafting the manuscript for content; study supervision, and coordination; obtaining funding; 3) final approval of the version to be submitted.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical standards
The study was carried out in accordance with the Declaration of Helsinki and approved by the local Ethics Committee of School of Medicine, University of Belgrade. All participants gave written informed consent prior to the inclusion to the study.
Rights and permissions
About this article
Cite this article
Marković, V., Stanković, I., Petrović, I. et al. Dynamics of impulsive–compulsive behaviors in early Parkinson’s disease: a prospective study. J Neurol 267, 1127–1136 (2020). https://doi.org/10.1007/s00415-019-09692-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-019-09692-4